Still the Same Story
Most times, the market environment is in a constant state of change, so when we report to you our latest thoughts on this page, there’s plenty to discuss—rotation among sectors, major moves in the indexes, earnings season or some big-picture that...
Read More
As we move into the third quarter, analysts at Goldman Sachs write that their baseline forecast is for the S&P 500 to gain 5% in the second half of the year. In their “vaccine upside” scenario, stocks rise by 14% from here; in “virus...
Read More
The Big Idea
If there was ever any doubt that digital payments is a big trend the coronavirus pandemic has squashed the argument.
Locked up at home, people have still needed to buy things and pay their bills. Businesses, from car and boat dealerships to to...
Read More
The market came into this week in an interesting position when looking at the trends—because of the bifurcated nature of the advance, the intermediate-term trend was actually on the fence as most indexes (even including the S&P 500) were within spitting distance of 50-day...
Read More
From Cabot Top Ten Trader
Overall, we’d say the story remains largely the same—there are some chinks in the armor overall, including some tertiary sentiment stuff (especially in the options markets) and short-term momentum measures (as the Nasdaq tested its highs yesterday, just 100 hit...
Read More
Tesla (TSLA) has new competition in the form of Nikola (NKLA) and Workhorse (WKHS). Is it still the best electric vehicle stock to buy today?
Read More
The stocks in the marijuana sector have pretty much traded in sync with the broad market since the March bottom, climbing strongly to late-May or early-June peaks and consolidating those gains since, with many stocks pulling back to sensible support levels.
Read More
The S&P 500 soared 46% from the March bottom in about 11 weeks, the fastest such rise in history. It couldn’t keep that up forever and it was bound to falter eventually.
Read More
The S&P 500 was up 20% in the second quarter. It was the best quarter for the market in decades. That’s what the headlines say. But they are a little misleading. The market hit a recent high on June 8th and has since back...
Read More
How to Learn More about the Companies You Own
As the new Chief Analyst for the Undervalued Stock Advisor, I’d like to thank you for reading this month’s letter. I know you have many sources of investment ideas and advice, and I appreciate your in...
Read More
Genetic testing makes it easier for medical professionals to understand and diagnose diseases since a big portion of health problems have genetic origins.
Read More
The market is strong, our portfolio is full, and the prospects for the months ahead look good. Thus I continue to recommend that you be heavily invested in stocks that help you meet your investing goals.
Read More
With a portfolio flush with positions and the market having gotten a little choppy lately we’re going to move incrementally more conservative today.
Read More
The major indexes are up as we start a holiday-shortened week, with the Dow up 373 points as of 11:15 am and the Nasdaq up 24 points. But it’s a heavy rotational day, with the broad market up but leading growth stocks getting hit.
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
It's been an up-and-down week for the major indexes—as of this morning, the S&P 500 was down less than 1% on the week, the Nasdaq was up less than 1% and the broader indexes (small/mid caps, etc.) were down a bit more than S&P.
...
Read More
You should remain bullish and flexible. Most of the evidence remains positive, including the trends of the major indexes and action of leading growth stocks.
Read More
The big news affecting the market this week is the upward trend in coronavirus cases in some states and the resulting concern that an economic rebound will be curbed sooner than hoped.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
